Blog Posts
Read blog posts that discuss our company history, team members, and other industry-relevant topics.
Pathology's Evolution: How Aignostics Builds on Charité Berlin's 300-Year Legacy
Aignostics started in 2018 within the walls of the Berlin Institute of Health at Charité – Universitätsmedizin Berlin, before ultimately spinning-out in 2020. But did you know that Charité Berlin has a rich history dating all the way back to 1710? Let’s explore some of that history, along with the history of pathology’s digital transformation, to understand the origins and drivers of Aignostics’ founding.
Meet Timo Haschler, Senior Scientific Project Manager on our Target and Biomarker Discovery team!
Timo Haschler and his team work closely with clients to identify novel drug targets and biomarkers. This includes the multi-year collaboration we announced with Bayer in 2024, to identify novel cancer targets and co-create a target identification platform to enable better patient identification, stratification, and selection for clinical trials.
